Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$3.97 -0.03 (-0.75%)
At close: Nov 10, 2026 · 4:00 PM EST

Oramed Pharmaceuticals (ORMP) Long-Term Debt Repayments (2023 - 2025)

Updated

Oramed Pharmaceuticals (ORMP) reported Long-Term Debt Repayments of $69.2 million for FY2025, up 39.7% from $49.55 million in FY2024.

Analysis

Oramed Pharmaceuticals (ORMP) Long-Term Debt Repayments (2023 - 2025) Analysis & Trends

  • According to Business Quant data, Long-Term Debt Repayments came in at $49.55 million in FY2024 (-0.9%) and $50 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oramed Pharmaceuticals 164.02 Mn -170.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 69.20 Mn
Jun 30, 2024 30.55 Mn
Mar 31, 2024 19.00 Mn
Dec 31, 2023 25.00 Mn
API Access

Oramed Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ORMP&period=max&api_key=YOUR_API_KEY